ANZMTG - Australia and New Zealand Melanoma Trials Group Home | Login
ANZMTG - Australia and New Zealand Melanoma Trials Group


Please enter your username and password.




ANZMTG 01.02 - Adjuvant Radiotherapy Trial

The use of radiotherapy after therapeutic lymphadenectomy for patients with melanoma at high risk of further lymph-node field and distant recurrence is controversial.

This is the first completed study to assess the effects of RT on regional recurrence, survival, morbidity and quality of life (QOL) in these patients.

ANZ Clinical Trials Registry number - 12607000063415

ANZMTG coordinator details:
Alan Lucas
Phone: +61 2 9911 7352

Trial publications:

Burmeister, B. H., M. A. Henderson, et al. (2012). "Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial." Lancet Oncol 13(6): 589-597.

Return to Previous Page